An attack from all angles! Multiphase particle systems that target respiratory infection. This project will result in advanced inhaled medicines for lung infection. Micron-particles will be engineered to have sustained drug release when deposited at sites of infection, yet avoid natural clearance and defence mechanisms. To study these systems, a series of characterisation, in vitro cell and in silico tools will be developed.
One for all and all for one: Engineering a drug delivery platform for DNA vaccines to the lung. Vaccination using next generation DNA plasmids is hindered by the lack of a suitable delivery technology. This project aims to develop a low-cost vaccination platform that can deliver any DNA vaccine via inhalation. High efficiency dry powder particles that contain a novel synthetic cell penetration enhancer and incorporate the drug delivery vehicle in a disposable inhalation device will be engineered ....One for all and all for one: Engineering a drug delivery platform for DNA vaccines to the lung. Vaccination using next generation DNA plasmids is hindered by the lack of a suitable delivery technology. This project aims to develop a low-cost vaccination platform that can deliver any DNA vaccine via inhalation. High efficiency dry powder particles that contain a novel synthetic cell penetration enhancer and incorporate the drug delivery vehicle in a disposable inhalation device will be engineered. The project aims to help develop a fundamental understanding of the properties that govern interactions in these systems, and a number of in vitro tools that can be used by the wider scientific community. Ultimately, a single platform that can be used for the vaccination of any disease will be created.Read moreRead less
Ultra-low dose dry powder inhaler technology for the treatment of respiratory diseases. Drug molecules are being developed for respiratory diseases, which are highly potent but beyond our capability in terms of delivery. Using a combination of high-end particle engineering and characterisation approaches, coupled with computational modelling, the project will develop a theoretical model that can be used to deliver ultra-low doses to the lungs.
Novel nano-composite particles for controlled-release drugs via inhalation. This project will explore a novel nano-medicine technology using nanocrystals in liposomes to design new composite particles to enable optimal release of antibiotics delivered by inhalation. Respiratory infection caused by multidrug-resistant bacteria is a major health problem worldwide. Controlled-release products using liposomes simplify dose regimen and enhance bacterial killing. Currently, aerosolised liposomes are l ....Novel nano-composite particles for controlled-release drugs via inhalation. This project will explore a novel nano-medicine technology using nanocrystals in liposomes to design new composite particles to enable optimal release of antibiotics delivered by inhalation. Respiratory infection caused by multidrug-resistant bacteria is a major health problem worldwide. Controlled-release products using liposomes simplify dose regimen and enhance bacterial killing. Currently, aerosolised liposomes are limited to liquid forms with limited control over release and stability. The project will provide new technology on manufacturing composite powders of antibiotics that may ultimately lead to the development of effective new treatments against drug-resistant bacteria.Read moreRead less
Novel nano-composite particles for controlled-release drugs via inhalation. This project will explore a novel nano-medicine technology using nanocrystals in liposomes to design new composite particles to enable optimal release of antibiotics delivered by inhalation. Respiratory infection caused by multidrug-resistant bacteria is a major health problem worldwide. Controlled-release products using liposomes simplify dose regimen and enhance bacterial killing. Currently, aerosolised liposomes are l ....Novel nano-composite particles for controlled-release drugs via inhalation. This project will explore a novel nano-medicine technology using nanocrystals in liposomes to design new composite particles to enable optimal release of antibiotics delivered by inhalation. Respiratory infection caused by multidrug-resistant bacteria is a major health problem worldwide. Controlled-release products using liposomes simplify dose regimen and enhance bacterial killing. Currently, aerosolised liposomes are limited to liquid forms with limited control over release and stability. The project will provide new technology on manufacturing composite powders of antibiotics that may ultimately lead to the development of effective new treatments against drug-resistant bacteria.Read moreRead less
One for all and all for one: Engineering a drug delivery platform for DNA vaccines to the lung. Vaccination using next generation DNA plasmids is hindered by the lack of a suitable delivery technology. This project aims to develop a low-cost vaccination platform that can deliver any DNA vaccine via inhalation. High efficiency dry powder particles that contain a novel synthetic cell penetration enhancer and incorporate the drug delivery vehicle in a disposable inhalation device will be engineered ....One for all and all for one: Engineering a drug delivery platform for DNA vaccines to the lung. Vaccination using next generation DNA plasmids is hindered by the lack of a suitable delivery technology. This project aims to develop a low-cost vaccination platform that can deliver any DNA vaccine via inhalation. High efficiency dry powder particles that contain a novel synthetic cell penetration enhancer and incorporate the drug delivery vehicle in a disposable inhalation device will be engineered. The project aims to help develop a fundamental understanding of the properties that govern interactions in these systems, and a number of in vitro tools that can be used by the wider scientific community. Ultimately, a single platform that can be used for the vaccination of any disease will be created.Read moreRead less
Ultra-low dose dry powder inhaler technology for the treatment of respiratory diseases. Drug molecules are being developed for respiratory diseases, which are highly potent but beyond our capability in terms of delivery. Using a combination of high-end particle engineering and characterisation approaches, coupled with computational modelling, the project will develop a theoretical model that can be used to deliver ultra-low doses to the lungs.
Production of nano-composite particles for inhalational delivery of combination drugs. The project seeks to create a new particle engineering process for pharmaceuticals. The successful outcome will i) enhance substantially the competitiveness of Australia’s research in functional nanomaterials and advanced biomaterials, and ii) benefit the Australian pharmaceutical industry in developing proprietary pharmaceutical formulations.